MLAB Mesa Laboratories, Inc.
Technology$106.17-2.27%ClosedMarket Cap: $586.6M
As of 2026-05-26
Valuation
P/E (TTM)
139.32
PEG
1.37
P/B
3.22
P/S
2.42
EV/EBITDA
15.22
DCF Value
$1.32
FCF Yield
6.3%
Div Yield
0.6%
Margins & Returns
Gross Margin
60.6%
Operating Margin
7.0%
Net Margin
1.5%
ROE
2.1%
ROA
0.9%
ROIC
1.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $65.1M | 64.2% | $8.0M | $3.6M | $— | $0.16 |
| Q2 null | $60.7M | 61.5% | $4.7M | $2.5M | $— | $0.16 |
| Q1 null | $59.5M | 54.6% | $3.1M | $4.7M | $— | $0.16 |
| Q4 null | $62.1M | 61.8% | $1.5M | $-7.1M | $— | $0.16 |
| FY null | $241.0M | 62.6% | $16.3M | $-2.0M | $— | $0.64 |
| Q3 null | $62.8M | 63.3% | $5.8M | $-1.7M | $— | $0.16 |
| Q2 null | $57.8M | 61.3% | $3.5M | $3.4M | $— | $0.16 |
| Q1 null | $58.2M | 64.0% | $5.6M | $3.4M | $— | $0.16 |
| Q4 null | $58.9M | 62.1% | $-271.3M | $-254.6M | $— | $0.16 |
| FY null | $216.2M | 61.6% | $-272.1M | $-254.2M | $— | $0.64 |
| Q3 2024 | $53.5M | 62.5% | $-67.0K | $2.1M | $0.39 | $0.16 |
| Q2 2024 | $53.2M | 60.4% | $-60.0K | $-1.2M | $-0.23 | $0.16 |